{"title":"Electroacupuncture Alleviates Migraine Possibly by Regulating KAT and Inhibiting nNOS Expression via the PGC-1α/PPARα/δ Signaling Pathway","authors":"Hui Zhang, Caiyan He, Minming Shao, Feng Zhang, Jiabi Li, Shengdong He","doi":"10.1007/s11064-026-04941-1","DOIUrl":null,"url":null,"abstract":"<div><p>Migraine is a widespread neurological disorder that presents a significant challenge to global health. Electroacupuncture (EA) has been explored as a therapeutic intervention for migraine, but its mechanisms are still poorly understood. Our study aimed to validate the therapeutic efficacy of EA for migraine and explore its underlying mechanism. An acute migraine rat model was established using nitroglycerin (NTG) injection. Mechanical pain thresholds were assessed using von Frey filaments. Histopathological examination was conducted through H&E staining. The expression of CGRP, c-Fos, PGC-1α, PPARα/δ, and KAT was detected by immunohistochemistry. Iba-1 expression was evaluated by immunofluorescence staining. The protein levels were assessed using Western blot, and the mRNA level of KAT was quantified via qRT-PCR. The concentrations of inflammatory cytokines, neuropeptide, and key metabolites were measured by ELISA. EA significantly alleviated the migraine-like symptoms, mechanical hyperalgesia, and pathological alterations caused by NTG. NTG decreased the levels of TRP, L-KYN, and KYNA, which were partially reversed by EA treatment. However, KAT II inhibitors attenuated the effects of EA. Moreover, PGC-1α activators reversed the effects of LPS on the PGC-1α/PPARα/δ signaling pathway, KAT protein expression and the release of inflammatory factor. EA upregulated the expression of PGC-1α, PPARα/δ, and KAT, reduced nNOS, SP, and CGRP levels and restored the content of TRP, L-KYN, and KYNA, which were reversed after PGC-1α inhibitors treatment. Our findings demonstrate that EA may alleviate migraine, at least in part, by regulating KAT and inhibiting nNOS expression associated with the PGC-1α/PPARα/δ signaling pathway.</p></div>","PeriodicalId":719,"journal":{"name":"Neurochemical Research","volume":"51 6","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurochemical Research","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s11064-026-04941-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Migraine is a widespread neurological disorder that presents a significant challenge to global health. Electroacupuncture (EA) has been explored as a therapeutic intervention for migraine, but its mechanisms are still poorly understood. Our study aimed to validate the therapeutic efficacy of EA for migraine and explore its underlying mechanism. An acute migraine rat model was established using nitroglycerin (NTG) injection. Mechanical pain thresholds were assessed using von Frey filaments. Histopathological examination was conducted through H&E staining. The expression of CGRP, c-Fos, PGC-1α, PPARα/δ, and KAT was detected by immunohistochemistry. Iba-1 expression was evaluated by immunofluorescence staining. The protein levels were assessed using Western blot, and the mRNA level of KAT was quantified via qRT-PCR. The concentrations of inflammatory cytokines, neuropeptide, and key metabolites were measured by ELISA. EA significantly alleviated the migraine-like symptoms, mechanical hyperalgesia, and pathological alterations caused by NTG. NTG decreased the levels of TRP, L-KYN, and KYNA, which were partially reversed by EA treatment. However, KAT II inhibitors attenuated the effects of EA. Moreover, PGC-1α activators reversed the effects of LPS on the PGC-1α/PPARα/δ signaling pathway, KAT protein expression and the release of inflammatory factor. EA upregulated the expression of PGC-1α, PPARα/δ, and KAT, reduced nNOS, SP, and CGRP levels and restored the content of TRP, L-KYN, and KYNA, which were reversed after PGC-1α inhibitors treatment. Our findings demonstrate that EA may alleviate migraine, at least in part, by regulating KAT and inhibiting nNOS expression associated with the PGC-1α/PPARα/δ signaling pathway.
期刊介绍:
Neurochemical Research is devoted to the rapid publication of studies that use neurochemical methodology in research on nervous system structure and function. The journal publishes original reports of experimental and clinical research results, perceptive reviews of significant problem areas in the neurosciences, brief comments of a methodological or interpretive nature, and research summaries conducted by leading scientists whose works are not readily available in English.